Aims Percutaneous implantation has already been used clinically and is a great option for treating young patients. The use of autologous tissue-engineered valved stents might solve the problem of degeneration and limited durability of biologi-cal heart valves. Methods and results Porcine pulmonary heart valves and small intestinal submucosa were obtained from a slaughterhouse. The intestinal submucosa was used to cover the inside of the porcine pulmonary valved stents. Endothelial cells (ECs) and auto
OBJECTIVES: Pulmonary valve insufficiency remains a leading cause for reoperations in congenital car...
OBJECTIVES: Pulmonary valve insufficiency remains a leading cause for reoperations in congenital car...
Background and aim of the study: Living tissue-engineered heart valves (TEHVs) based on rapidly degr...
Aims: The objective was to implant a stented decellularised tissue-engineered heart valve (sdTEHV) p...
Aims: The objective was to implant a stented decellularised tissue-engineered heart valve (sdTEHV) p...
AIMS: The objective was to implant a stented decellularised tissue-engineered heart valve (sdTEHV) p...
ObjectiveWe sought to investigate a placement of a percutaneous low-profile prosthetic valve constru...
In a European consortium, a decellularized tissue-engineered heart valve (dTEHV) based on vessel-der...
In a European consortium, a decellularized tissue-engineered heart valve (dTEHV) based on vessel-der...
ObjectivesTransfemoral application of pulmonary heart valves has been studied for the past 10 years....
Perventricular pulmonary valve implantation (PPVI) of a xenograft valve can be a less invasive techn...
BackgroundEndovascular application of pulmonary heart valves has been recently introduced clinically...
Glutaraldehyde-treated, surgical bioprosthetic heart valves undergo structural degeneration within 1...
ObjectivesPulmonary valve insufficiency remains a leading cause for reoperations in congenital cardi...
Glutaraldehyde-treated, surgical bioprosthetic heart valves undergo structural degeneration within 1...
OBJECTIVES: Pulmonary valve insufficiency remains a leading cause for reoperations in congenital car...
OBJECTIVES: Pulmonary valve insufficiency remains a leading cause for reoperations in congenital car...
Background and aim of the study: Living tissue-engineered heart valves (TEHVs) based on rapidly degr...
Aims: The objective was to implant a stented decellularised tissue-engineered heart valve (sdTEHV) p...
Aims: The objective was to implant a stented decellularised tissue-engineered heart valve (sdTEHV) p...
AIMS: The objective was to implant a stented decellularised tissue-engineered heart valve (sdTEHV) p...
ObjectiveWe sought to investigate a placement of a percutaneous low-profile prosthetic valve constru...
In a European consortium, a decellularized tissue-engineered heart valve (dTEHV) based on vessel-der...
In a European consortium, a decellularized tissue-engineered heart valve (dTEHV) based on vessel-der...
ObjectivesTransfemoral application of pulmonary heart valves has been studied for the past 10 years....
Perventricular pulmonary valve implantation (PPVI) of a xenograft valve can be a less invasive techn...
BackgroundEndovascular application of pulmonary heart valves has been recently introduced clinically...
Glutaraldehyde-treated, surgical bioprosthetic heart valves undergo structural degeneration within 1...
ObjectivesPulmonary valve insufficiency remains a leading cause for reoperations in congenital cardi...
Glutaraldehyde-treated, surgical bioprosthetic heart valves undergo structural degeneration within 1...
OBJECTIVES: Pulmonary valve insufficiency remains a leading cause for reoperations in congenital car...
OBJECTIVES: Pulmonary valve insufficiency remains a leading cause for reoperations in congenital car...
Background and aim of the study: Living tissue-engineered heart valves (TEHVs) based on rapidly degr...